Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 70 entries
View as:

Trial Evaluating the Efficacy and the Safety of FOLFIRINOX3 Treatment in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer in First Line of Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05988814 Org: User:
Start: 01/24/24 End: 07/24/29 Due: 07/24/30

Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01022918 Org: User:
Start: 01/31/09 End: 01/31/11 Due: 01/31/12

Mechanisms of Anti COVID-19 Humoral and Cellular Immune Response After Vaccination in a Sample of Patients and Salaried Staff From a French Anti-cancer Center

Phase: N/A Priority: Normal
NCT ID: NCT04935528 Org: User:
Start: 06/02/21 End: 01/26/22 Due: 01/26/23

Health-Related Quality of Life Coupled With Therapeutic Information on Compliance to Endocrine Therapy in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04176809 Org: User:
Start: 05/14/21 End: 10/31/25 Due: 10/31/26

Assessment of Health Related Quality of Life in Women Who Underwent Breast Reconstruction After Radical Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04938505 Org: User:
Start: 05/04/19 End: 05/04/25 Due: 05/04/26

Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04169841 Org: User:
Start: 02/10/20 End: 08/10/27 Due: 08/10/28

Study of Exosomes in Monitoring Patients With Sarcoma (EXOSARC)

Phase: N/A Priority: Normal
NCT ID: NCT03800121 Org: User:
Start: 11/19/18 End: 11/19/24 Due: 11/19/25

Pilot Study With the Aim to Quantify a Stress Protein in the Blood and in the Urine for the Monitoring and Early Diagnosis of Malignant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02662621 Org: User:
Start: 12/15/15 End: 04/08/19 Due: 04/08/20

Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus

Phase: N/A Priority: Normal
NCT ID: NCT01348217 Org: User:
Start: 05/06/11 End: 12/17/18 Due: 12/17/19

Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas

Phase: N/A Priority: Normal
NCT ID: NCT03181477 Org: User:
Start: 04/07/17 End: 09/02/25 Due: 09/02/26

Evaluation of the Impact of a Pharmaceutical Interview on the Adherence to Hormonotherapy in Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04142476 Org: User:
Start: 06/25/19 End: 02/07/23 Due: 02/07/24

Immunomonitoring of Breast Cancer Patients During Systemic Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04925856 Org: User:
Start: 05/26/20 End: 05/26/30 Due: 05/26/31

Value of Information of Secondary dAta in ONCOGEnetics

Phase: N/A Priority: Normal
NCT ID: NCT04972409 Org: User:
Start: 12/09/19 End: 12/09/22 Due: 12/09/23

Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)

Phase: N/A Priority: Normal
NCT ID: NCT05259319 Org: User:
Start: 12/05/22 End: 12/05/24 Due: 12/05/25

Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01810744 Org: User:
Start: 05/31/13 End: 05/31/15 Due: 05/31/16

Preoperative Chemo-radiation With IG-IMRT Dose Escalation for Locally Advanced Rectal Cancers

Phase: N/A Priority: Normal
NCT ID: NCT03200249 Org: User:
Start: 12/22/16 End: 01/07/20 Due: 01/07/21

Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01043536 Org: User:
Start: 09/30/09 End: - Due: -

Evaluation and Modeling of the G-CSF Effect on the Evolution of Neutrophils During Chemotherapy Based on Eribulin

Phase: N/A Priority: Normal
NCT ID: NCT02841722 Org: User:
Start: 12/03/15 End: 01/10/20 Due: 01/10/21

What Benefit of a Full Analysis of Exome? Routine Care Study in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02840604 Org: User:
Start: 05/15/16 End: 04/29/19 Due: 04/29/20

Study Evaluating the Utility of 18F-FDG PET in Assessing Early Response to Neoadjuvant Chemotherapy in Patients With Mammary Gland Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02386709 Org: User:
Start: 03/25/15 End: 03/25/28 Due: 03/25/29

Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01210872 Org: User:
Start: 09/30/09 End: - Due: -

Randomized Study Versus Placebo for the Prevention of Neurotoxicity Induced by Weekly PACLITAXEL

Phase: N/A Priority: Normal
NCT ID: NCT05695313 Org: User:
Start: 04/12/24 End: 06/30/26 Due: 06/30/27

Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide Regeneration

Phase: N/A Priority: Normal
NCT ID: NCT05296317 Org: User:
Start: 09/02/22 End: 10/02/25 Due: 10/02/26

Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01044485 Org: User:
Start: 11/30/08 End: - Due: -

Neoadjuvant Database

Phase: N/A Priority: Normal
NCT ID: NCT04031612 Org: User:
Start: 09/09/09 End: 09/30/24 Due: 09/30/25